Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
37.36
-0.39 (-1.03%)
Jun 13, 2025, 2:55 PM - Market open
Claritev Market Cap
Claritev has a market cap or net worth of $614.06 million as of June 13, 2025. Its market cap has increased by 58.23% in one year.
Market Cap
614.06M
Enterprise Value
5.23B
1-Year Change
58.23%
Ranking
Category
Stock Price
$37.36
Market Cap Chart
Since April 3, 2020, Claritev's market cap has increased from $243.00M to $614.06M, an increase of 152.70%. That is a compound annual growth rate of 19.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2025 | 620.47M | 159.60% |
| Dec 31, 2024 | 239.01M | -74.44% |
| Dec 29, 2023 | 935.26M | 27.25% |
| Dec 30, 2022 | 734.99M | -74.01% |
| Dec 31, 2021 | 2.83B | -46.98% |
| Dec 31, 2020 | 5.33B | 2,094.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.64B |
| Johnson & Johnson | 376.43B |
| Novo Nordisk | 353.20B |
| AbbVie | 334.73B |
| UnitedHealth Group | 275.58B |
| Abbott Laboratories | 233.36B |
| Novartis AG | 232.35B |
| AstraZeneca | 227.75B |